Cargando…
The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe rare progressive inherited neuromuscular disorder, leading to loss of ambulation (LOA) and premature mortality. The standard of care for patients with DMD has been treatment with corticosteroids for the past decade; however a synthesis of con...
Autores principales: | Szabo, Shelagh M., Salhany, Renna M., Deighton, Alison, Harwood, Meagan, Mah, Jean, Gooch, Katherine L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141220/ https://www.ncbi.nlm.nih.gov/pubmed/34022943 http://dx.doi.org/10.1186/s13023-021-01862-w |
Ejemplares similares
-
Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review
por: Szabo, Shelagh M., et al.
Publicado: (2019) -
Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy
por: Audhya, Ivana, et al.
Publicado: (2023) -
Characterizing demographics, comorbidities, and costs of care among populations with Duchenne muscular dystrophy with Medicaid and commercial coverage
por: Klimchak, Alexa C, et al.
Publicado: (2021) -
Characterizing the Occurrence of Key Clinical Milestones in Duchenne Muscular Dystrophy in the United States Using Real-World Data
por: Szabo, Shelagh M., et al.
Publicado: (2022) -
Factors associated with the health-related quality of life among people with Duchenne muscular dystrophy: a study using the Health Utilities Index (HUI)
por: Szabo, Shelagh M., et al.
Publicado: (2022)